ANIP Operating Income Growth
Ani Pharmaceuticals Inc · Operating Income Growth
ANIP Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported888.70%period ending
ANIP TTM Operating Income YoY % (24.92% → 888.70%)
Year-over-year change
High-resolution chart · PNG
ANIP operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 888.6958% | |
| 1,811.6146% | |
| 18,922.774% | |
| 400.8556% | |
| -69.7159% | |
| -88.7328% | |
| -98.7567% | |
| -72.2144% | |
| 162.2895% | |
| 1,026.6591% | |
| 233.1264% | |
| 169.1563% | |
| 132.1957% | |
| 90.0166% | |
| 11.3337% | |
| -286.4667% | |
| -533.5253% | |
| -1,109.456% | |
| -148.4578% | |
| 25.1166% | |
| 43.1543% | |
| -224.8843% | |
| -197.9512% | |
| -164.7365% | |
| -146.7818% | |
| -87.6385% | |
| -53.7572% | |
| 3.7516% | |
| 15.5457% | |
| 9.8641% | |
| 24.8156% | |
| 40.6553% | |
| 46.4152% | |
| 58.8455% | |
| 41.0877% | |
| -11.1821% | |
| -18.5347% | |
| -33.8935% | |
| -38.5963% | |
| -32.6712% | |
| -30.7778% | |
| 10.4341% | |
| 63.451% | |
| 193.0833% | |
| 596.5122% | |
| 553.5091% | |
| 917.5552% | |
| 233.0742% | |
| 133.8255% | |
| 133.8155% | |
| 84.5026% | |
| 57.5183% | |
| 47.9751% | |
| 72.7602% | |
| 69.7469% | |
| 59.2677% | |
| 43.2844% | |
| 13.9276% | |
| -20.0211% | |
| -23.4311% | |
| -32.9712% | |
| -46.5% | |
| -47.6196% | |
| -164.0794% | |
| -131.9752% | |
| -89.5425% | |
| -63.3778% | |
| 6.9986% | |
| -26.326% | |
| -68.4776% | |
| -107.7442% | |
| -657.7335% | |
| -400.4621% | |
| -320.6472% | |
| -352.3269% | |
| 139.3787% | |
| 148.4541% | |
| 149.9658% | |
| 136.9778% | |
| 29.3503% | |
| 26.3151% | |
| 22.9346% | |
| 24.1664% | |
| -19.5555% | |
| -53.4413% | |
| -73.811% | |
| -102.5054% | |
| -107.5718% | |
| -102.8908% | |
| -84.0103% | |
| -58.6795% | |
| 2.554% | |
| -8.6633% | |
| -27.065% | |
| -39.5793% | |
| -113.8068% | |
| -16.2359% | |
| 19.5019% | |
| 25.3751% | |
| 24.9182% |